Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "ge"

9608 News Found

Multimodal AI emerges as next leap in predictive healthcare
Opinion | May 22, 2026

Multimodal AI emerges as next leap in predictive healthcare

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond


QIAGEN and NVIDIA partner on AI drug discovery
R&D | May 21, 2026

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases


India reaffirms commitment to global women and child health agenda at WHA 2026
Policy | May 21, 2026

India reaffirms commitment to global women and child health agenda at WHA 2026

Minister J.P. Nadda holds bilateral meeting with Helen Clark, Board Chair of the Partnership for Maternal, Newborn and Child Health in Geneva


National Genomics Infrastructure becomes first global certified core lab for Epigenica’s EpiFinder platform
R&D | May 21, 2026

National Genomics Infrastructure becomes first global certified core lab for Epigenica’s EpiFinder platform

NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro


Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration
R&D | May 21, 2026

Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration

This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access


Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal
Hospitals | May 21, 2026

Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal

Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India


Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data
Clinical Trials | May 21, 2026

Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data

Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials


Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates
News | May 20, 2026

Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates

The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform


Gleneagles hospital performs customised 3D-printed hip reconstruction surgery
Hospitals | May 20, 2026

Gleneagles hospital performs customised 3D-printed hip reconstruction surgery

A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern


Lupin gets tentative FDA nod for Revefenacin inhalation solution
Drug Approval | May 20, 2026

Lupin gets tentative FDA nod for Revefenacin inhalation solution

The drug is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD)